Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MS › Tupelo › NPI 1598875460
Hospital

North Mississippi Medical Center, INC.

North Mississippi Medical Center, INC. was paid $117.67M by Medicaid between Jan 2018 and Dec 2024, across 637 billing codes. Its largest line is 99284, emergency room visit (serious) — 15% of everything it billed.

33Billing provider infoNORTH MISSISSIPPI MEDICAL CENTER, INC.
TUPELO, MS 38801
33aNPI1598875460assigned 08/30/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$117.67M
24GClaims2,717,440
24DCodes billed637
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Mississippi

Rank by total paid#2 of 77
Median peer was paid$8.23M
This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official TOPPIN, BRUCE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018424,758$19.13M
2019414,972$19.65M
2020340,293$15.22M
2021349,379$16.02M
2022390,236$16.52M
2023413,590$17.88M
2024incomplete384,212$13.24M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 92,272 75,088 $17.45M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.7% 36,561 30,141 $9.08M
G0378 Hospital observation service, per hour 4.7% 11,954 10,171 $5.49M
J2357 Injection, omalizumab, 5 mg 4.6% 3,728 2,138 $5.43M
97530 Therapeutic activities, direct patient contact, each 15 minutes 4.0% 78,807 14,398 $4.72M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 3.7% 32,237 27,052 $4.37M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.5% 39,412 30,997 $4.17M
J9271 Injection, pembrolizumab, 1 mg 3.2% 937 629 $3.77M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 2.1% 49,226 12,481 $2.45M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 22,630 15,912 $2.25M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.9% 15,050 9,087 $2.24M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.4% 11,108 9,632 $1.69M
625 more codes
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.4% 42,349 $1.69M
J0897 Injection, denosumab, 1 mg 1.3% 2,890 $1.54M
J2323 Injection, natalizumab, 1 mg 1.3% 539 $1.51M
96361 Intravenous infusion, hydration; each additional hour 1.2% 30,295 $1.45M
71045 Radiologic examination, chest; single view 1.2% 36,759 $1.42M
96375 Therapeutic injection; each additional sequential IV push 1.0% 42,385 $1.21M
93458 <1% 1,278 $1.15M
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 12,976 $1.15M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 9,785 $1.12M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 4,593 $1.10M
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 82,557 $1.02M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 8,437 $962K
47562 <1% 391 $943K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 2,293 $857K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 41,957 $856K
87428 <1% 15,344 $853K
80053 Comprehensive metabolic panel <1% 117,402 $814K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 22,598 $757K
70450 Computed tomography, head or brain; without contrast material <1% 14,693 $748K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 5,638 $718K
95811 <1% 2,047 $713K
59025 Fetal non-stress test <1% 6,994 $712K
J9299 Injection, nivolumab, 1 mg <1% 233 $699K
71046 Radiologic examination, chest; 2 views <1% 18,368 $672K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 137,977 $647K
64493 <1% 1,708 $641K
78815 Positron emission tomography (PET) for limited area imaging <1% 1,334 $528K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 4,331 $486K
J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg <1% 1,211 $469K
62323 <1% 2,311 $465K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 5,014 $420K
99213 Doctor's office visit, returning patient (routine) <1% 13,660 $418K
76819 Fetal biophysical profile; without non-stress testing <1% 6,098 $410K
76820 <1% 5,326 $404K
86885 <1% 6,282 $397K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 8,425 $393K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 5,357 $387K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 1,017 $371K
92526 <1% 7,330 $362K
77386 <1% 1,926 $359K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 2,254 $352K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 231 $337K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,344 $326K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 11,248 $325K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 25,115 $325K
36902 <1% 324 $324K
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) <1% 325 $313K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 7,090 $297K
93304 <1% 840 $295K
86900 <1% 6,683 $291K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 3,875 $290K
36430 <1% 2,994 $286K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 21,760 $283K
84443 Thyroid stimulating hormone (TSH) <1% 21,134 $265K
88307 <1% 1,642 $259K
71275 Computed tomographic angiography, chest, with contrast material <1% 3,137 $255K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 3,240 $243K
74019 <1% 4,264 $243K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,146 $243K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 2,214 $241K
67028 Intravitreal injection of a pharmacologic agent <1% 2,809 $241K
G0379 Direct admission of patient for hospital observation care <1% 1,844 $237K
76821 <1% 3,224 $234K
J0475 Injection, baclofen, 10 mg <1% 676 $231K
97597 <1% 4,099 $229K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,584 $225K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 7,243 $224K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 7,557 $208K
77336 <1% 3,422 $207K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 7,415 $205K
99214 Doctor's office visit, returning patient (more involved) <1% 3,780 $204K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 9,813 $203K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,076 $201K
72125 Computed tomography, cervical spine; without contrast material <1% 4,483 $190K
96415 <1% 4,311 $189K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,547 $189K
96367 <1% 5,594 $184K
83880 <1% 8,987 $184K
84484 <1% 27,903 $184K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,318 $177K
72100 <1% 3,735 $172K
87086 Culture, bacterial; quantitative colony count, urine <1% 28,053 $172K
88342 <1% 2,704 $170K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 863 $167K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,685 $167K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 3,101 $158K
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units <1% 1,921 $157K
92523 <1% 1,297 $156K
87081 <1% 29,462 $155K
77334 <1% 870 $154K
87536 <1% 3,275 $154K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,089 $152K
77412 <1% 2,301 $151K
88304 <1% 3,776 $143K
J0178 Injection, aflibercept, 1 mg <1% 628 $141K
76801 <1% 1,948 $141K
96401 <1% 4,166 $140K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,651 $138K
J3262 Injection, tocilizumab, 1 mg <1% 205 $137K
J2469 Injection, palonosetron hcl, 25 mcg <1% 3,166 $136K
86923 <1% 2,834 $135K
74018 <1% 3,016 $132K
86901 <1% 8,859 $131K
20610 <1% 1,756 $123K
97161 <1% 3,349 $122K
87807 <1% 10,179 $117K
80061 Lipid panel <1% 11,541 $117K
80048 Basic metabolic panel (calcium, ionized) <1% 19,539 $115K
75625 <1% 93 $114K
93308 <1% 618 $110K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,541 $108K
73030 <1% 3,260 $107K
P9016 Red blood cells, leukocytes reduced, each unit <1% 1,322 $106K
82731 <1% 2,139 $104K
36415 Collection of venous blood by venipuncture <1% 51,791 $103K
72170 <1% 2,497 $99K
81001 <1% 43,654 $97K
93971 <1% 2,328 $97K
83690 <1% 21,433 $96K
72141 <1% 1,078 $96K
73562 <1% 2,561 $92K
86003 <1% 2,112 $91K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 5,064 $89K
85027 <1% 20,743 $87K
81025 <1% 13,419 $86K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 13,628 $85K
71250 <1% 2,231 $82K
87186 <1% 12,375 $82K
77300 <1% 623 $82K
87077 <1% 12,865 $81K
76642 <1% 2,350 $80K
77066 Tomosynthesis, mammo <1% 1,363 $79K
83874 <1% 10,013 $79K
97162 <1% 1,996 $76K
99215 Doctor's office visit, returning patient (complex) <1% 1,064 $73K
96417 <1% 2,717 $72K
15275 <1% 123 $72K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 365 $72K
86360 <1% 2,852 $71K
10060 <1% 679 $71K
73630 <1% 1,994 $70K
82553 <1% 10,125 $70K
80305 <1% 15,223 $69K
93923 <1% 1,698 $69K
J2505 Injection, pegfilgrastim, 6 mg <1% 32 $64K
83655 <1% 6,321 $64K
82728 <1% 8,423 $63K
86355 <1% 2,857 $61K
72040 <1% 1,794 $61K
87040 <1% 9,312 $61K
72072 <1% 1,285 $61K
84702 <1% 5,330 $60K
12001 <1% 621 $60K
82607 <1% 6,431 $60K
77065 Tomosynthesis, mammo <1% 1,582 $60K
73130 <1% 1,737 $59K
73560 <1% 1,868 $59K
73610 <1% 1,455 $59K
86357 <1% 2,852 $59K
77301 <1% 127 $59K
94010 <1% 5,987 $58K
86359 <1% 2,852 $58K
73502 <1% 2,086 $57K
70486 <1% 1,125 $57K
36600 <1% 1,827 $57K
78227 <1% 200 $55K
74230 <1% 820 $55K
76770 <1% 973 $54K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit <1% 630 $54K
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units <1% 1,381 $53K
76830 Ultrasound, transvaginal <1% 712 $53K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,480 $53K
73590 <1% 1,485 $52K
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg <1% 176 $52K
84703 <1% 9,083 $51K
83735 <1% 13,235 $51K
J9312 Injection, rituximab, 10 mg <1% 17 $49K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,526 $49K
J2182 Injection, mepolizumab, 1 mg <1% 29 $49K
95812 <1% 222 $48K
93312 <1% 384 $46K
93880 <1% 862 $44K
36591 <1% 9,159 $43K
12011 <1% 460 $43K
70496 <1% 540 $43K
97165 <1% 1,250 $42K
73090 <1% 1,074 $42K
36561 <1% 43 $42K
86480 <1% 1,293 $41K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg <1% 50 $41K
G0127 Trimming of dystrophic nails, any number <1% 4,167 $40K
86738 <1% 3,640 $40K
75716 <1% 57 $40K
49083 <1% 188 $40K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 603 $39K
86140 <1% 13,922 $38K
64483 <1% 120 $38K
95990 <1% 605 $37K
97116 <1% 2,145 $37K
82784 <1% 3,923 $37K
84146 <1% 2,825 $37K
15271 <1% 61 $37K
73620 <1% 1,074 $36K
D2930 Prefabricated stainless steel crown - primary tooth <1% 677 $36K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 589 $35K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 769 $35K
92134 <1% 5,386 $34K
82378 <1% 4,044 $34K
83520 <1% 2,108 $33K
74178 <1% 258 $33K
87070 <1% 5,026 $32K
73110 <1% 790 $32K
G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography <1% 415 $32K
97113 <1% 642 $31K
11719 <1% 1,618 $31K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,280 $31K
81003 <1% 18,501 $31K
96416 <1% 277 $31K
82746 <1% 4,018 $31K
93017 <1% 283 $30K
97167 <1% 776 $30K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 11,957 $30K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 76 $29K
83605 <1% 5,230 $29K
70491 <1% 334 $29K
72110 <1% 782 $28K
83550 <1% 6,654 $28K
83970 <1% 1,328 $28K
87641 <1% 1,423 $27K
86038 <1% 2,847 $27K
83036 Hemoglobin; glycosylated (A1C) <1% 4,334 $26K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 18,999 $26K
84439 <1% 3,484 $26K
86703 <1% 2,299 $25K
73600 <1% 677 $24K
70498 <1% 312 $24K
83540 <1% 7,120 $24K
80076 <1% 6,988 $23K
87400 <1% 1,071 $22K
85379 <1% 3,385 $22K
82803 <1% 1,735 $22K
86225 <1% 3,060 $21K
80177 <1% 2,391 $21K
86235 <1% 562 $20K
85610 <1% 9,020 $20K
84153 <1% 1,518 $20K
86803 <1% 2,321 $20K
86300 <1% 2,538 $20K
93970 <1% 239 $20K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 55 $20K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 705 $20K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 3,193 $19K
97166 <1% 396 $19K
96411 <1% 566 $19K
85730 <1% 5,966 $19K
73552 <1% 632 $19K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 21,817 $19K
86160 <1% 3,275 $18K
92611 <1% 500 $18K
97760 <1% 546 $18K
83615 <1% 4,778 $17K
71101 <1% 310 $17K
82565 <1% 8,545 $17K
82962 <1% 11,050 $17K
76825 <1% 53 $17K
72131 <1% 458 $16K
82550 <1% 4,705 $16K
82247 <1% 3,707 $16K
85652 <1% 11,739 $16K
78226 <1% 78 $16K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 297 $15K
80074 <1% 491 $15K
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 2,915 $15K
87205 <1% 5,009 $15K
11056 <1% 285 $15K
19083 <1% 40 $14K
88184 <1% 163 $14K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 680 $14K
87046 <1% 1,639 $14K
29125 <1% 227 $13K
84550 <1% 4,378 $13K
93925 <1% 278 $13K
94726 <1% 467 $13K
87493 <1% 446 $13K
86592 <1% 4,161 $13K
64447 <1% 118 $12K
92610 <1% 407 $12K
82570 <1% 4,191 $12K
73120 <1% 182 $12K
87045 <1% 1,506 $12K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 347 $12K
J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg <1% 15 $12K
80164 <1% 1,271 $12K
73080 <1% 285 $11K
31720 <1% 86 $11K
11057 <1% 196 $11K
84450 <1% 2,936 $11K
64635 <1% 15 $11K
93226 <1% 194 $11K
77338 <1% 114 $11K
64415 <1% 126 $11K
86308 <1% 2,174 $11K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 161 $10K
86334 <1% 1,300 $10K
90791 Psychiatric diagnostic evaluation <1% 337 $10K
84165 <1% 2,366 $10K
93225 <1% 182 $9K
87075 <1% 1,632 $9K
93975 <1% 62 $9K
0240U <1% 1,833 $9K
64450 <1% 82 $9K
90686 <1% 2,059 $9K
84156 <1% 3,821 $9K
J7030 Infusion, normal saline solution , 1000 cc <1% 33,635 $9K
80047 <1% 883 $9K
86704 <1% 1,386 $9K
D7140 Extraction, erupted tooth or exposed root <1% 60 $9K
87340 <1% 1,577 $8K
78306 <1% 60 $8K
85014 <1% 4,859 $8K
12002 <1% 100 $8K
84132 <1% 2,873 $8K
97163 <1% 137 $8K
77290 <1% 44 $8K
64615 <1% 203 $8K
78264 <1% 43 $7K
62321 <1% 44 $7K
82948 <1% 2,111 $7K
88312 <1% 386 $7K
82140 <1% 1,032 $7K
27096 <1% 95 $7K
G0008 Administration of influenza virus vaccine <1% 2,329 $7K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 11,925 $7K
85045 <1% 3,228 $7K
90834 Psychotherapy session, about 45 minutes <1% 620 $7K
73060 <1% 202 $7K
88112 <1% 375 $6K
41899 Unlisted procedure, dentoalveolar structures <1% 12 $6K
84238 <1% 398 $6K
88185 <1% 484 $6K
73140 <1% 154 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 18,392 $6K
86902 <1% 23 $6K
86665 <1% 158 $6K
73100 <1% 173 $6K
82150 <1% 1,017 $6K
93325 <1% 3,180 $5K
J9045 Injection, carboplatin, 50 mg <1% 724 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 143 $5K
86769 <1% 182 $5K
88360 <1% 113 $5K
84100 <1% 1,416 $5K
80069 <1% 1,351 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 41,447 $5K
76641 <1% 76 $5K
93321 <1% 1,545 $5K
86431 <1% 1,359 $5K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 140 $5K
85576 <1% 248 $5K
70360 <1% 97 $4K
80143 <1% 635 $4K
73221 <1% 57 $4K
86200 <1% 627 $4K
72050 <1% 114 $4K
85018 <1% 2,523 $4K
97542 <1% 169 $4K
83883 <1% 659 $4K
80179 <1% 620 $4K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 20 $4K
84481 <1% 274 $4K
20553 <1% 47 $4K
82272 <1% 1,563 $4K
76827 <1% 53 $3K
J3489 Injection, zoledronic acid, 1 mg <1% 174 $3K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 2,615 $3K
86706 <1% 569 $3K
85049 <1% 713 $3K
96376 <1% 11,014 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 14,029 $3K
93976 <1% 53 $3K
86664 <1% 144 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 9,482 $3K
20552 <1% 48 $3K
87210 <1% 754 $3K
82010 <1% 488 $3K
82274 <1% 186 $3K
76870 <1% 41 $3K
73070 <1% 64 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 4,836 $3K
J1756 Injection, iron sucrose, 1 mg <1% 853 $3K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 1,621 $2K
87899 <1% 274 $2K
86430 <1% 451 $2K
82310 <1% 1,559 $2K
72197 <1% 25 $2K
82465 <1% 695 $2K
83721 <1% 320 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 7,005 $2K
97535 Self-care/home management training, each 15 minutes <1% 695 $2K
93990 <1% 99 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,655 $2K
77280 <1% 42 $2K
80050 General health panel <1% 1,132 $2K
51702 <1% 65 $2K
80185 <1% 181 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 34 $2K
G0144 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision <1% 57 $2K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 1,192 $2K
99205 Prolong outpt/office vis <1% 121 $2K
73521 <1% 53 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 17,429 $2K
91010 <1% 15 $2K
72158 <1% 12 $2K
J9190 Injection, fluorouracil, 500 mg <1% 262 $2K
87177 <1% 180 $2K
86696 <1% 112 $2K
31624 <1% 15 $2K
95816 <1% 12 $2K
82947 <1% 604 $2K
89050 <1% 660 $2K
87116 <1% 394 $1K
74174 <1% 19 $1K
87102 <1% 413 $1K
J1815 Injection, insulin, per 5 units <1% 4,284 $1K
90715 <1% 2,345 $1K
J9267 Injection, paclitaxel, 1 mg <1% 293 $1K
84134 <1% 133 $1K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 290 $1K
86039 <1% 175 $1K
86695 <1% 113 $1K
82800 <1% 184 $1K
A9270 Non-covered item or service <1% 15,420 $1K
J2997 Injection, alteplase recombinant, 1 mg <1% 14 $1K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 112 $1K
84460 <1% 251 $1K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 12 $1K
36589 <1% 13 $1K
82043 <1% 576 $1K
88173 <1% 82 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 16,184 $1K
84403 <1% 56 $1K
96402 <1% 64 $989.77
J2704 Injection, propofol, 10 mg <1% 15,888 $929.64
72128 <1% 32 $895.16
99152 <1% 9,641 $884.52
89055 <1% 276 $877.58
86880 <1% 83 $872.45
92650 <1% 40 $869.04
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,590 $841.16
77470 <1% 13 $832.18
77002 <1% 947 $808.50
84155 <1% 1,184 $781.65
L3030 Foot, insert, removable, formed to patient foot, each <1% 73 $755.90
87015 <1% 343 $747.20
86757 <1% 26 $700.29
64494 <1% 1,148 $675.32
88311 <1% 254 $672.68
97014 <1% 114 $655.93
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 19,867 $652.81
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,444 $645.05
Q3014 Telehealth originating site facility fee <1% 113 $638.06
J0640 Injection, leucovorin calcium, per 50 mg <1% 26 $636.85
97032 <1% 140 $605.18
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 1,306 $599.51
87503 <1% 35 $577.12
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 294 $566.50
96101 <1% 39 $561.38
J7050 Infusion, normal saline solution, 250 cc <1% 9,524 $542.93
76942 <1% 324 $538.39
76882 <1% 16 $533.15
J1980 Injection, hyoscyamine sulfate, up to 0.25 mg <1% 909 $528.20
86376 <1% 33 $523.69
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 138 $514.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 4,293 $503.09
74220 <1% 12 $463.60
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 26 $404.34
88321 <1% 28 $403.17
87206 <1% 252 $397.98
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 6,755 $363.14
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 799 $358.32
82805 <1% 14 $354.45
99406 <1% 325 $348.32
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 716 $343.54
C9399 Unclassified drugs or biologicals <1% 162 $338.72
82085 <1% 64 $335.93
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 3,657 $328.30
82785 <1% 17 $319.10
83001 <1% 24 $309.04
86618 <1% 22 $306.60
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 1,989 $300.75
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 1,319 $288.16
J0690 Injection, cefazolin sodium, 500 mg <1% 10,700 $272.88
82955 <1% 35 $269.91
J3480 Injection, potassium chloride, per 2 meq <1% 2,185 $269.07
82670 <1% 14 $257.95
82040 <1% 50 $244.11
J2550 Injection, promethazine hcl, up to 50 mg <1% 5,850 $242.90
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 168 $232.80
J9263 Injection, oxaliplatin, 0.5 mg <1% 23 $227.64
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 392 $219.22
88313 <1% 23 $212.66
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 13,012 $211.14
87209 <1% 14 $195.57
87420 <1% 19 $187.96
82077 <1% 46 $186.65
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 9,158 $181.50
C1769 Guide wire <1% 3,550 $181.07
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 935 $148.80
83010 <1% 58 $148.51
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,503 $146.83
87329 <1% 13 $146.52
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 860 $144.65
94729 <1% 486 $143.00
J0780 Injection, prochlorperazine, up to 10 mg <1% 2,608 $138.00
88341 <1% 2,088 $137.50
90656 <1% 292 $104.64
J2060 Injection, lorazepam, 2 mg <1% 2,138 $97.20
90732 <1% 18 $85.04
77012 <1% 242 $74.16
80178 <1% 12 $73.40
90670 <1% 13 $66.57
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 2,169 $64.35
J0461 Injection, atropine sulfate, 0.01 mg <1% 197 $58.48
84145 <1% 3,444 $54.42
92201 <1% 389 $53.53
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 2,128 $52.36
82330 <1% 14 $49.61
J1644 Injection, heparin sodium, per 1000 units <1% 5,602 $44.36
86593 <1% 15 $41.56
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 260 $40.70
82525 <1% 15 $39.25
82365 <1% 14 $34.83
82668 <1% 12 $33.82
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 218 $26.40
J1940 Injection, furosemide, up to 20 mg <1% 2,441 $23.07
J3370 Injection, vancomycin hcl, 500 mg <1% 2,544 $21.71
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 615 $18.02
C9113 Injection, pantoprazole sodium, per vial <1% 2,157 $15.93
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 637 $14.72
J0736 Injection, clindamycin phosphate, 300 mg <1% 204 $12.12
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,468 $10.45
91300 <1% 17 $9.33
J2471 Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg <1% 153 $6.53
95874 <1% 39 $5.89
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 238 $3.90
92202 <1% 77 $3.62
J1956 Injection, levofloxacin, 250 mg <1% 37 $2.94
99153 Mod sedat endo service >5yrs <1% 4,360 $2.20
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 112 $2.13
77063 Screening digital breast tomosynthesis, bilateral <1% 1,239 $1.52
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 388 $1.02
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 300 $0.66
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 135 $0.66
36592 <1% 22 $0.13
J1920 Injection, labetalol hydrochloride, 5 mg <1% 33 $0.07
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 0% 701 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 5,042 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 563 $0.00
C1788 Port, indwelling (implantable) 0% 70 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 235 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 1,436 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 1,241 $0.00
77387 0% 1,103 $0.00
C9257 Injection, bevacizumab, 0.25 mg 0% 901 $0.00
97598 0% 139 $0.00
84112 0% 934 $0.00
Q4186 Epifix, per square centimeter (add-on, list separately in addition to primary procedure) 0% 712 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 727 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 1,056 $0.00
G8997 Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 201 $0.00
C1776 Joint device (implantable) 0% 99 $0.00
C1874 Stent, coated/covered, with delivery system 0% 94 $0.00
G8996 Swallowing functional limitation, current status at therapy episode outset and at reporting intervals 0% 178 $0.00
J7510 Prednisolone oral, per 5 mg 0% 90 $0.00
93356 0% 52 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 332 $0.00
76937 0% 71 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 63 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 0% 43 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 363 $0.00
0042T 0% 13 $0.00
J3260 Injection, tobramycin sulfate, up to 80 mg 0% 72 $0.00
64636 0% 15 $0.00
84166 0% 25 $0.00
77085 0% 33 $0.00
J1020 Injection, methylprednisolone acetate, 20 mg 0% 16 $0.00
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 0% 17 $0.00
J2305 Injection, nitroglycerin, 5 mg 0% 72 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 1,363 $0.00
36416 0% 4,001 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 307 $0.00
A4648 Tissue marker, implantable, any type, each 0% 180 $0.00
96368 0% 574 $0.00
77001 0% 557 $0.00
93320 0% 338 $0.00
94760 0% 986 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 1,449 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 429 $0.00
11045 0% 199 $0.00
99243 0% 1,432 $0.00
J7999 Compounded drug, not otherwise classified 0% 3,243 $0.00
G0009 Administration of pneumococcal vaccine 0% 200 $0.00
A9561 Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries 0% 41 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 860 $0.00
J1741 Injection, ibuprofen, 100 mg 0% 448 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 173 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 144 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 94 $0.00
77417 0% 276 $0.00
C2623 Catheter, transluminal angioplasty, drug-coated, non-laser 0% 71 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 190 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 204 $0.00
94660 0% 68 $0.00
80320 0% 513 $0.00
80329 0% 193 $0.00
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 15 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 243 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 147 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 51 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 90 $0.00
G8998 Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting 0% 44 $0.00
J3490 Unclassified drugs 0% 52 $0.00
J0456 Injection, azithromycin, 500 mg 0% 22 $0.00
J3410 Injection, hydroxyzine hcl, up to 25 mg 0% 16 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 31 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTOPPIN, BRUCE (CORPORATE SECRETARY)
Parent organizationNORTH MISSISSIPPI MEDICAL CENTER, INC
Same official

Other billing entities under TOPPIN, BRUCE

Full network →
ProviderLocationPaid
North Mississippi Medical Clinics INCTupelo, MS$16.92M
Monroe Health Services, INC.Amory, MS$16.44M
Clay County Medical CorporationWest Point, MS$16.13M
Pontotoc Health Services, INC.Pontotoc, MS$11.55M
North Mississippi Medical Center INC.Tupelo, MS$7.71M
Clay County Medical CorporationWest Point, MS$7.30M
Webster Health Services, INC.Eupora, MS$6.05M
Marion Regional Medical Center, INC.Hamilton, AL$5.48M
North Mississippi Medical Center INC.Tupelo, MS$2.95M
Webster Health Services, INC.Eupora, MS$2.84M
Webster Health Services, INC.Eupora, MS$2.53M
North Mississippi Medical Center INC.Saltillo, MS$1.48M
North Mississippi Medical Center, INC.Tupelo, MS$1.25M
North Mississippi Faculty Practice Plan LLCTupelo, MS$1.14M
North Mississippi Medical Center, INCTupelo, MS$995K
North Mississippi Emergency Services, INC.Tupelo, MS$958K
Pontotoc Health Services, INC.New Albany, MS$912K
Pontotoc Health Services, INC.Pontotoc, MS$835K
North Mississippi Medical Center, INC.Tupelo, MS$799K
North Mississippi Medical CenterTupelo, MS$798K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.